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Abstract
Background/Aims: Insulin-secreting islet β-cells adapt to the insulin resistance associated 
with pregnancy by increasing functional β-cell mass, but the placental signals involved in 
this process are not well defined. In the current study, we analysed expression of G-protein 
coupled receptor (GPCR) mRNAs in mouse islets and islet GPCR ligand mRNAs in placenta 
during pregnancy to generate an atlas of potential interactions between the placenta and 
β-cells to inform future functional studies of islet adaptive responses to pregnancy. Methods: 
Quantative RT-PCR arrays were used to measure mRNA expression levels of: (i) 342 GPCRs in 
islets from non-pregnant mice, and in islets isolated from mice on gestational days 12 and 
18; (ii) 126 islet GPCR ligands in mouse placenta at gestational days 12 and 18. Results: At 
gestational day 12, a time of rapid expansion of the β-cell mass, 189 islet GPCR mRNAs were 
quantifiable, while 79 of the 126 known islet GPCR ligand mRNAs were detectable in placental 
extracts.  Approximately half of the quantifiable placental GPCR ligand genes were of unknown 
function in β-cells.  The expression of some islet GPCR and placental ligand mRNAs varied 
during pregnancy, with altered expression of both GPCR and ligand mRNAs by gestational 
day 18. Conclusion: The current study has revealed numerous potential routes for interaction 
between the placenta and islets, and offers an atlas to inform further functional studies of 
their roles in adaptive responses to pregnancy, and in the regulation of the β-cell mass.
IntroductionThe increased insulin resistance that develops during normal pregnancy is compensated 
for by adaptations in islet β-cells, including higher rates of insulin secretion and increased 
β-cell mass [1-3]. Failure of the β-cells to adapt appropriately leads to glucose intolerance 
and the eventual development of overt gestational diabetes mellitus (GDM) [2-4]. In rodents, 
the β-cell expansion during gestation occurs over a relatively short and well-defined period 
[5, 6], offering a useful experimental model in which to study the regulation of functional 
β-cell mass. Islet β-cell adaptive responses occur after placentation and are rapidly reversed 
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post-partum, consistent with placental signals playing a major role in informing β-cells of the 
gestational stage via circulating mediators. It is well established that the placental lactogens 
and prolactin play important roles in metabolic adaptations during pregnancy, but these 
cannot account for all of the β-cell adaptive responses because the time-course of elevations 
in their circulating levels does not match that of increases in β-cell mass [7-11]. The current 
study aimed to identify other placentally-derived mediators with the potential to influence 
β-cells to facilitate future functional studies into changes in the endocrine capacity of islets 
in pregnancy.
G-protein coupled receptors (GPCRs) are the most abundant mammalian family of cell 
surface receptors, and the human genome encodes 384 functional, non-odorant GPCRs [12]. 
We have demonstrated that human islets express 293 different GPCRs (“GPCRome”) that 
enable β-cells and other islet endocrine cells to recognise and respond to a vast array of 
physiological signals [13], and islets from inbred C57 and outbred ICR (CD1) mice express 
mRNAs encoding 227 and 279 GPCRs respectively [14]. We have also recently studied cross-
talk between mesenchymal stromal cells (MSCs) and islets using a mRNA library for known 
peptide or protein ligands for the islet GPCRome to identify MSC-derived secreted products 
(“secretome”) with the potential to influence islet cell function via activation of GPCRs [15]. We here apply these approaches in pregnant mice to characterize the placental secretome 
and the islet GPCRome to identify novel placental ligands/islet GPCRs that may be involved 
in adaptive responses of islets to pregnancy.
Materials and Methods
Isolation of islets and placentas
Female CD1 mice (Charles River, UK, 8 weeks old) were mated and the subsequent presence of a 
vaginal plug was designated day 0 of pregnancy. Tissue samples were prepared at two stages of pregnancy: 
gestational day (gd) 12 in mid-pregnancy when β-cell mass expansion is maximal; and gd18 in late pregnancy 
when the β-cell mass is no longer expanding [6]. Placenta were removed and extracted immediately while 
islets were isolated from whole pancreas by collagenase digestion, as described previously [15].
Measurement of gene expression by quantitative RT-PCR
Quantative RT-PCR (qRT-PCR) was used to measure the mRNA expression levels of: (i) 342 GPCRs in 
islets isolated from non-pregnant mice, and from islets isolated at gds12 and 18; (ii) 126 islet GPCR ligands 
in mouse placenta at gd12 and gd18, using groups of six mice at each time point. Total RNA was isolated 
using RNeasy Mini kits (Qiagen), and RNA quality was assessed using the ND1000 spectrophotometer 
(Nanodrop). RNA samples with A
260
/A
280
 ratios between 1.8 and 2.2 were considered sufficiently pure for 
experimental use and were converted into cDNAs using the High Capacity Reverse Transcription Kit (Applied 
Biosystems), according to the manufacturer’s instructions. cDNA samples were interrogated by quantitative 
RT-PCR (qRT-PCR) using a LC480 Light Cycler (Roche). Bioinformatically validated QuantiTect primer assays 
(Qiagen) were used for the expression analysis using a QuantiTect SYBR Green PCR Kit (Qiagen). A full list of 
primers is shown (for all online suppl. material, see www.karger.com/doi/10.1159/000487357) in Suppl. 
Tables 1 and 2. Reactions producing specific DNA products (homogeneous melting curves) were further 
analysed by 2% agarose gel electrophoresis in TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 
7.6) to confirm that sizes of generated products matched the primer specifications.  Relative expression of 
target genes was determined by the 2-ΔΔCt method using a Ct value of 20 for all screening and quantification, 
and GAPDH as a reference gene [16].
Statistical analysis
Differences between two groups were analysed by unpaired Student’s t-test with Welch’s correction. 
For comparisons between more than two groups, one-way analysis of variance (ANOVA) with Tukey’s (equal 
variances) or Dunnett’s T3 (unequal variances) post hoc tests were used. Group variances were compared 
using Bartlett’s test for equal variances. Data were processed using Prism (GraphPad) or SPSS Statistics 23 
(IBM) software and expressed as means±SEM.
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Fig. 2. Islet GPCRome on gestational day 18. Red markers: islet GPCR 
mRNAs upregulated on gd18 vs non-pregnant islets; black markers: 
mRNAs downregulated on gd18 vs non-pregnant islets. Solid triangles 
show mRNAs upregulated in gd18 vs gd12 islets; solid circles show 
mRNAs not differentially expressed on gd18 vs gd12 islets; solid 
squares show mRNAs downregulated in gd18 vs gd12 islets. Values are 
expressed as means ± SEM, n = 4-6; all mRNAs p<0.05. The full data set 
and abbreviations are shown (see online suppl. material) in the Suppl. 
Table 4.
Results
Islet GPCRome during 
pregnancy
We compared GPCR 
mRNA expression levels in 
islets isolated from non-
pregnant mice with islets isolated from pregnant mice 
on gd12 and gd18.  In all is-
let extracts the most abun-
dantly expressed GPCR mR-
NAs were GPR56, GPR158, 
FFAR1, GIPR, GALR1 and 
GALR3, with expression lev-els an order of magnitude greater than those of the 
other GPCR mRNAs, con-
sistent with our previous 
report [14].  There were no 
significant differences in the 
expression of these GPCR 
mRNAs between non-preg-
nant, gd12 and gd18 islets 
so they were omitted from 
the expression plots (Fig. 
1, 2) for ease of scaling, al-
though the qRT-PCR data 
for these GPCR mRNAs are included in (see online sup-
pl. material) Suppl. Tables 3 
and 4.  When compared to 
non-pregnant expression 
levels 71 GPCR mRNAs were 
differentially expressed on 
gd12, as shown in Fig. 1 and 
(see online suppl. material) 
Suppl. Table 3, with 26 of these being upregulated 
(Fig.  1, red symbols). By 
day 18 of gestation 66 GPCR 
mRNAs were differen-
tially expressed compared 
to non-pregnant islets, as 
shown in Fig. 2 and (see on-
line suppl. material) Suppl. 
Table 4, with 35 of these 
being upregulated (Fig.  2, 
red symbols). Figures 1 and 
2 also show the changes in 
GPCR mRNA expression be-
tween gd12 and gd18, respectively, with upregulated mRNAs being denoted by triangles, 
down-regulated mRNAs being denoted by squares and mRNAs whose expression did not 
change being shown by solid circles
Fig. 1. Islet GPCRome on gestational day 12. Red markers: islet GPCR 
mRNAs upregulated on gd12 vs non-pregnant islets; black markers: 
mRNAs downregulated on gd12 vs non-pregnant islets. Solid triangles 
show mRNAs upregulated in gd12 vs gd18 islets; solid circles show 
mRNAs not differentially expressed on gd12 vs gd18 islets; solid 
squares show mRNAs downregulated in gd12 vs gd18 islets. Values are 
expressed as means ± SEM, n = 4-6; all mRNAs p<0.05. Full data set 
and abbreviations are shown (see online suppl. material) in the Suppl. 
Table 3.
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Figure 1. Islet GPCRome on gestational day 12  Red markers: islet GPCR mRNAs upregulated on gd12 vs non-pregnant islets;   black markers: mRNAs downregulated on gd12 vs non-pregnant islets. Solid triangles show mRNAs upregulated in gd12 vs gd18 islets; solid circles show mRNAs not differentially expressed on gd12 vs gd18 islets; solid squares show mRNAs downregulated in gd12 vs gd18 islets. Values are expressed as means ± SEM, n = 4-6; all mRNAs p<0.05. Full data set and abbreviations are shown in the Supplementary Table 3. 
 
   
Figure 2. Islet GPCRome on gestational day 18  Red markers: islet GPCR mRNAs upregulated on gd18 vs non-pregnant islets;   black markers: mRNAs downregulated on gd18 vs non-pregnant islets. Solid triangles show mRNAs upregulated in gd18 vs gd12 islets; solid circles show mRNAs not differentially expressed on gd18 vs gd12 islets; solid squares show mRNAs downregulated in gd18 vs gd12 islets. Values are expressed as means ± SEM, n = 4-6; all mRNAs p<0.05. The full data set and abbreviations are shown in the Supplementary Table 4. 
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Mouse placental 
secretome
On gd12, a time of 
rapid β-cell expansion [6], 
79 out of 126 known islet 
GPCR ligand mRNAs were 
expressed at detectable levels in mouse placental 
extracts, as shown in Fig. 
3 and (see online suppl. 
material) Suppl. Table 5. 
Analysis of the expression 
of the same mRNA species 
in placental extracts 
at gd18, when β-cell 
expansion has ceased [6], 
indicated expression of 62 
GPCR ligand mRNAs (Fig. 4, 
see online suppl. material, 
Suppl. Table 6).  Comparison of the data sets generated from placentas retrieved at 
gd12 and gd18 revealed a 
number of time-dependent changes in the placental 
secretome. Thus, expression 
of 35 islet GPCR ligand 
mRNAs was upregulated 
(Fig. 3, red symbols), while 
the expression of 17 mRNAs 
was downregulated (Fig. 3, 
blue symbols). Conversely, 
comparing expression at 
gd18 with that at gd12 
indicated that expression 
of 26 islet GPCR ligand 
mRNAs was upregulated 
(Fig. 4, red symbols), while 
the expression of 9 mRNAs 
was downregulated (Fig. 4, 
blue symbols). In addition, 
expression of 27 placental 
islet GPCR ligand mRNAs 
did not change between 
gd12 and gd18 (Figs. 3 and 
4, black symbols).
Cross talk between 
placenta and islets
Placenta-derived islet 
GPCR ligands that have reported effects on insulin secretion and/or β-cell proliferation were 
identified by manual searches on PubMed. As shown in Fig. 5, over 50% of the placental 
ligands that were identified in our secretome analyses were of unknown function in islets. 
Of the remaining ligands whose effects on β-cells or islets have been reported, over 50% 
Fig. 3. Placental GPCR ligand secretome on gestational day 12. Red 
markers: mRNAs upregulated on gd12 vs gd18 expression levels; black 
markers: mRNAs not differentially expressed on gd12 vs gd18 expres-
sion levels; blue markers: mRNAs downregulated on gd12 vs gd18 
expression levels. Values are expressed as means ± SEM, n = 4-6; red 
and blue p<0.05. Full data set and abbreviations are shown (see online 
suppl. material) in Suppl. Table 3.
 
  
Fi ure 3. Placental GPCR ligand secretome on gestational day 12  Red markers: mRNAs upregulated on gd12 vs gd18 expression levels; black markers: mRNAs not differentially expressed on gd12 vs gd18 expression levels; blue markers: mRNAs downregulated on gd12 vs gd18 expression levels. Values are expressed as means ± SEM, n = 4-6; red and blue p<0.05. Full data set and abbreviations are shown in Supplementary Table 3. 
 
 
  
Fig. 4. Placental GPCR ligand secretome on gestational day 18. Red 
markers: mRNAs upregulated on gd18 vs gd12 expression levels; black 
markers: mRNAs not differentially expressed on gd18 vs gd12 expres-
sion levels; blue markers: mRNAs downregulated on gd18 vs gd12 
expression levels. Values are expressed as means ± SEM, n = 4-6; red 
and blue p<0.05. Full data set and abbreviations are shown (see online 
suppl. material) in Suppl. Table 6.
 
 
  
Figure 4. Placental GPCR ligand secretome on gestational day 18  Red markers: mRNAs upregulated on gd18 vs gd12 expression levels; black markers: mRNAs not differentially expressed on gd18 vs gd12 expression levels; blue markers: mRNAs downregulated on gd18 vs gd12 expression levels. Values are expressed as means ± SEM, n = 4-6; red and blue p<0.05. Full data set and abbreviations are shown in Supplementary Table 6.  
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had stimulatory effects, 
around 20% had inhibitory 
effects, and the remainder 
were reported to have both stimulatory and inhibitory 
effects on β-cell function 
(Fig. 5). The full data set is 
shown (see online suppl. 
material) in Suppl. Table 7.To focus on placental ligands and their cognate 
islet GPCRs that are likely to be involved in adaptive 
responses to pregnancy we 
identified islet GPCR mRNAs 
that showed increased 
expression at gd12 versus 
non-pregnant and/or gd18 
expression, and for which 
ligands were expressed 
in the placenta at gd12. 
Fig. 6 shows eight GPCR 
mRNAs whose expression 
was upregulated in islets 
on gd12 and whose ligand 
mRNAs were also expressed in the placenta retrieved 
from mice at gd12. Of these 
eight islet GPCRs, ligands for three receptors (Crh/Ucn2, 
F2, Sst) were upregulated, the ligand for one receptor (Cck) was downregulated, and the ligands for four receptors (Avp, Nmd, Adm) 
did not change, when 
comparing the ligand mRNA 
expression in the placenta 
at gd12 versus gd18.
Discussion
Under normal circum-
stances in adults β-cells 
are essentially non-prolif-erative and the functional 
β-cell mass is static. How-
ever, increases in peripheral insulin resistance induce a compensatory increase in 
β-cell mass [1-3].  Failure 
of the β-cell mass to adapt 
appropriately to pregnancy or obesity results in β-cell insufficiency, leading to glucose in-
tolerance and the eventual development of overt GDM or type 2 diabetes mellitus (T2DM), 
Fig. 5. Reported effects of placental GPCR ligand secretome on β-cell 
function. The reported effects on β-cell function of placental GPCR 
ligands expressed on gd12 (A) or gd18 (B) are either unknown (Un-
known, solid black: A=56%, B=54%), stimulatory (Stimulation, verti-
cal bars: A=22%, B=22%), inhibitory (Inhibition, cross hatch: A=9%, 
B=10%) or both stimulatory and inhibitory depending on the spe-
cies and experimental conditions (Stim/Inh, horizontal bars: A=13%, 
B=14%).  The full data set is shown (see online suppl. material) in 
Suppl. Table 7.
 
  
Figure 5. Reported effects of placental GPCR ligand secretome on β-cell function   The reported effects on β-cell function of placental GPCR ligands expressed on gd12 (A) or gd18 (B) are either unknown (Unknown, solid black: A=56 , B=54%), stimulatory (Sti ulation, vertical bars: A=22%, B=22%), inhibitory (Inhibition, cross hatch: A=9%, B=10%) or both stimulatory and inhibitory depending on the species and experimental conditions (Stim/Inh, horizontal bars: A=13%, B=14%).  The full data set is shown in Supplementary Table 7.   
    
 
 
  
Fig. 6. Mouse islet GPCR mRNAs and placental ligand mRNAs at 
gestational day 12. Bars show mRNA expression levels of 8 islet GPCRs 
which were upregulated on gd12 (solid bars) compared to gd18 
(cross-hatched bars). Expression levels in islets isolated from non-
pregnant animals is shown by the stippled bars, where detectable. 
Text shows expression status of placental ligand mRNAs at gd12. Red 
text: ligand mRNAs upregulated on gd12 vs gd18; blue text: ligand 
mRNA downregulated on gd12 vs gd18; green text: ligand mRNAs 
not deferentially expressed on gd12 vs gd18; N: not detectable/not 
quantifiable expression;  a: ligand mRNAs expressed in the placenta on 
gd12 but not expressed on gd18.  Values are expressed as means ± SEM, 
n = 4-6; one-way ANOVA test * p<0.05, ** p<0.01.
 
  
Figure 6. Mouse islet GPCR mRNAs and placental ligand mRNAs at gestational day 12  Bars show mRNA expression levels of 8 islet GPCRs which were upregulated on gd12 (solid bars) compared to gd18 (cross-hatched bars). Expression levels in islets isolated from non-pregnant animals is s own by the stippled bars, where detectable. Text how  expression status of placental ligand mRNAs at gd12. Red text: ligand mRNAs upregulated on gd12 vs gd18; blue text: ligand mRNA downregulated on gd12 vs gd18; green text: ligand mRNAs not deferentially expressed on gd12 vs gd18;  N: not detectable/not quantifiable expression;  a: ligand mRNAs expressed in the placenta on gd12 but not expressed on gd18.  Values are expressed as means ± SEM, n = 4-6; one-way ANOVA test * p<0.05, ** p<0.01.         
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respectively. Understanding the β-cell adaptive responses may inform therapeutic interven-
tions in women at risk of developing GDM, and also in the much larger population at risk of 
developing T2DM.  In addition, understanding how the β-cell functional mass is upregulated during pregnancy may have important repercussions for the generation in vitro of β-cell 
graft material for the transplantation therapy of Type 1 diabetes. The aim of this study was 
therefore to produce an atlas of the islet GPCRome and placental peptide ligand secretome 
during pregnancy to identify novel placentally-expressed ligands with the potential to influ-
ence β-cell function.Most previous studies on placental regulation of islet function have focused on ligands 
whose receptors are coupled via the JAK/STAT pathways, such as the placental lactogens, or 
whose receptors have intrinsic tyrosine kinase activity, such as the growth factor receptor 
families. We chose to investigate GPCRs because this is the most abundant family of cell surface 
receptors, and because we have previously demonstrated that β-cells express hundreds of 
GPCRs, many of unknown function [13, 14]. Some GPCRs have been implicated previously in 
β-cell adaptive response to pregnancy. For example, serotonin mediates the pro-proliferative and insulinotropic action of lactogenic hormones in maternal β-cells through activation of its 
Gαs protein-coupled GPCR, Htr2b, during mid-gestation in mice [8].
We have identified considerable potential for cross-talk between placenta and islets via 
secreted placental ligands that could interact with islet GPCRs. Not all of the ligands whose 
mRNAs were identified in the mouse placental secretome will be involved in regulating 
maternal responses to pregnancy. Some, such as the chemokines, are likely to be involved in 
local maintenance of placental function [17] while others, such as placental growth hormones, 
may be involved in the regulation of fetal development [18]. However, the expression of 
so many ligands with the potential to influence islet function via GPCR signalling, and the 
knowledge that lactogenic hormones cannot alone account for all β-cell adaptive responses 
to pregnancy [7] are consistent with the notion that some of these ligands may be involved 
in placenta/β-cell cross-talk.
The current study aimed to produce an atlas of islet GPCRs/placenta-derived ligands 
to guide future functional studies. However, given the large numbers of GPCR mRNAs 
expressed by the maternal islets, and the large range of potential ligand mRNAs expressed 
by the placenta, identifying functional GPCR/ligand combinations requires the application 
of some selection criteria. One strategy is to compare the patterns of expression with those 
of the lactogenic hormones known to be involved in β-cell adaptive responses to pregnancy 
[7, 10]. Thus, expression of the islet GPCR should increase when the β-cell mass is actively 
expanding (gd12) and may be down-regulated when the β-cell mass expansion is complete 
(gd18). Similarly, the placental ligand(s) should be highly expressed during the β-cell 
expansion phase, and may fall towards the end of gestation.  Our data identified a number 
of islet GPCR mRNAs upregulated on gd12 whose ligand mRNAs were expressed by the 
placenta at gd12, so some of these may be useful candidates for further functional studies. 
For example, corticotrophin releasing hormone (CRH) is an interesting candidate. We have 
shown that both islet Crhr1 and placental Crh were upregulated on gd12 compared to gd18, and previous in vitro studies have demonstrated that CRH enhances insulin secretion [19, 
20] and β-cell proliferation [20]. Together, these observations are consistent with a potential 
role for CRH in signaling from the placenta to the islet during pregnancy.
In conclusion, the mechanisms underlying the well-documented β-cell adaptations to 
pregnancy are not fully understood, although the failure of these mechanisms is implicated 
in the development of GDM. The current study has revealed numerous potential routes for 
interaction between the placenta and β-cells, and offer an atlas to guide further functional 
studies of their roles in islet adaptive responses to pregnancy.
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